Risk adapted treatment strategy in advanced disease - A chance for cure?

被引：0
|
作者：
Sleijfer, Stefan [1 ]
机构：
[1] Erasmus Univ, Ctr Med, Daniel Hoed Canc Ctr, Dept Med Oncol, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] A chance to cut is not always a chance to cure- fasciotomy in the treatment of rattlesnake envenomation: A retrospective poison center study
    Darracq, Michael A.
    Cantrell, F. Lee
    Klauk, Bryan
    Thornton, Stephen L.
    [J]. TOXICON, 2015, 101 : 23 - 26
  • [22] Risk Adapted Therapeutic Strategy of Acute Myeloid Leukemia
    Mohty, Razan
    Massoud, Radwan
    Chakhachiro, Zaher
    Mahfouz, Rami
    Nassif, Samer
    Elcheikh, Jean
    Bazarbachi, Ali
    [J]. BLOOD, 2019, 134
  • [23] Risk adapted Treatment of Osteoporosis Reply
    Pfeilschifter, Johannes
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (27) : 1440 - 1440
  • [24] Do not miss a second (and possibly last) chance to cure Hodgkin's disease
    Yahalom, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (03): : 595 - 597
  • [25] Editorial: Testicular malignancies - High chance of cure - Continuing opportunities to refine treatment
    Rowland, RG
    [J]. JOURNAL OF UROLOGY, 2003, 170 (04): : 1168 - 1168
  • [26] Migration background - a disease risk or a health chance?
    Schenk, L
    [J]. GESUNDHEITSWESEN, 2005, 67 (07) : 525 - 525
  • [27] Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
    Green, Margaret L.
    Leisenring, Wendy
    Stachel, Daniel
    Pergam, Steven A.
    Sandmaier, Brenda M.
    Wald, Anna
    Corey, Lawrence
    Boeckh, Michael
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (11) : 1687 - 1699
  • [28] Treatment strategy for IgA nephropathy depends on the risk of disease progression
    [J]. Drugs & Therapy Perspectives, 1999, 13 (1) : 5 - 8
  • [29] Treatment strategy in patients with atherosclerotic disease and high atherotrombotic risk
    Kalnins, U
    Zakke, I
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (04) : 31 - 31
  • [30] Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease
    Tarockoff, Meri
    Gonzalez, Teresita
    Ivanov, Stanislav
    Sandoval-Sus, Jose
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (10) : 1313 - 1326
12345